rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Sandoz Inc

Rediff.com  »  News  »   Sandoz Inc

  News for Sandoz Inc

  • Business

A Mylan win in US court could hit Ranbaxy

Ranbaxy Laboratories Ltd might lose the 180-day opportunity to exclusively sell its generic version of Novartis AG's hypertension drug Diovan if a US district court rules in favour of Mylan, which......

US oral contraceptive market draws Indian pharma

Indian pharmaceutical companies, which always wanted a big share in the global copycat drug market, are betting high on the oral contraceptive (OC) market in America.Apart from Glenmark, Sun......

US patent lawsuit against Dr Reddy's

US-based drug discovery firm Albany Molecular Research, Inc (Amri) has filed two new patent infringement lawsuits in the US District Court in New Jersey against Dr. Reddy's Laboratories Ltd., Dr.......

Eli Lilly files suit against Lupin, Aurobindo

US-based pharma giants Eli Lilly and company has filed a case against two Indian drug makers, Aurobindo Pharma and Lupin alleging infringement of patent of its anti-depressant drug Cymbalta.Filing......

Matrix Labs' Belgian buy turns sour

Hyderabad-based Matrix Laboratories, a subsidiary of the US-based Mylan Inc, has announced its intention to divest Docpharma, a Belgium-based generic drug firm, which it acquired in 2005 for $263......
  Web results for Sandoz Inc
Novartis delivered sales growth (cc), significant margin expansion (cc) and strong innovation in Q1[1]; now with a more focused portfolio

· *Continuing* *operations[1] saw sales, core[2] operating income and core EPS grow (cc[2]) in Q1* · Net sales were USD 11.9 billion (-7%, +3%... ...

http://newsr.in/n/Press+Releases/754zwr0sp/Novartis-delivered-sales-growth-cc-significant-margin.htm
Teva offers to buy Mylan for $40.1 billion

NEW YORK: Teva Pharmaceutical Industries made an unsolicited offer to buy Mylan NV for about $40.1 billion, in the drug industry's largest takeover... ...

http://economictimes.indiatimes.com/news/international/business/teva-offers-to-buy-mylan-for-40-1-billion/articleshow/47007705.cms
As Daiichi exits, Sun Pharma faces prospect of a mammoth rival

On Tuesday, Japanese drug maker Daiichi Sankyo sold its entire 9% stake in Sun Pharma for Rs. 20,456 crore. Photo: Hemant Mishra/Mint Tel... ...

http://www.livemint.com/Companies/RDMR0nJoi2iRVIDaCYtUaM/As-Daiichi-exits-Sun-Pharma-faces-prospect-of-a-mammoth-riv.html
Apricus Biosciences, Inc. to Present at Taglich Brothers 12th Annual Investment Conference

Comments April 20, 2015 - NEW YORK, NY Taglich Brothers, Inc. is pleased to announce that Apricus Biosciences, Inc. (NASDAQ: APRI) will be... ...

http://www.andhranews.net/Business/2015/Apricus-Biosciences-Present-Taglich-Brothers-15350.htm
Momenta Presents Key Glatopa(TM) (glatiramer acetate injection) Data at American Academy of Neurology Annual Meeting

Company Showcases a Subset of the Various Methods Used to Show Equivalence of Once Daily Glatopa(TM) and Daily COPAXONE(R) 20 mg CAMBRIDGE,... ...

http://www.bizwireexpress.com/showstoryGNW.php?storyid=67361

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z